Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

(2016) Mingming Zhang et al.   PLoS One

The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: How different are they from their normal counterparts?

(2014) Ł. Sędek et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study

(2014) C. Fossat et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Hematogones: An overview

(2013) S.P. Chantepie et al.   LEUKEMIA RESEARCH

Has MRD monitoring superseded other prognostic factors in adult ALL?

(2012) M. Bruggemann et al.   BLOOD

Adult acute lymphoblastic leukemia

(2010) Stefan Faderl et al.   CANCER

Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia

(2009) Tariq Muzzafar et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia

(2009) M. Djokic et al.   HAEMATOLOGICA

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

(2008) M. J. Borowitz et al.   BLOOD

Treatment of Adult Acute Lymphoblastic Leukemia

(2008) Nicola Gökbuget et al.   SEMINARS IN HEMATOLOGY